Karyopharm Therapeutics Inc (KPTI)

1.06 -0.04 (-3.64%) USD  |  NASDAQ  |  Apr 30, 12:25
More

Karyopharm Therapeutics Cash and Short Term Investments (Quarterly): 191.44M for Dec. 31, 2023

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2023 191.44M
September 30, 2023 208.32M
June 30, 2023 236.76M
March 31, 2023 260.38M
December 31, 2022 277.97M
September 30, 2022 148.38M
June 30, 2022 170.85M
March 31, 2022 205.31M
December 31, 2021 228.62M
September 30, 2021 204.21M
June 30, 2021 235.89M
March 31, 2021 224.36M
December 31, 2020 249.24M
September 30, 2020 263.04M
June 30, 2020 296.72M
March 31, 2020 352.13M
December 31, 2019 261.96M
September 30, 2019 267.53M
June 30, 2019 217.16M
March 31, 2019 264.42M
December 31, 2018 328.20M
September 30, 2018 206.77M
Date Value
June 30, 2018 241.12M
March 31, 2018 130.92M
December 31, 2017 146.47M
September 30, 2017 119.41M
June 30, 2017 143.45M
March 31, 2017 109.88M
December 31, 2016 129.55M
September 30, 2016 126.81M
June 30, 2016 122.74M
March 31, 2016 136.42M
December 31, 2015 175.63M
September 30, 2015 195.24M
June 30, 2015 221.19M
March 31, 2015 246.41M
December 31, 2014 205.72M
September 30, 2014 227.13M
June 30, 2014 132.31M
March 31, 2014 144.89M
December 31, 2013 155.97M
September 30, 2013 52.93M
June 30, 2013 61.67M
December 31, 2012 0.391M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

148.38M
Minimum
Sep 2022
352.13M
Maximum
Mar 2020
236.86M
Average
235.89M
Median
Jun 2021

Cash and Short Term Investments (Quarterly) Benchmarks

Geron Corp 333.70M
Arbutus Biopharma Corp 126.00M
Verastem Inc 137.13M
Actinium Pharmaceuticals Inc 76.68M
Chimerix Inc 182.84M